Prevention of Human Rhinovirus Infection by Multivalent Fab Molecules Directed against ICAM-1

AUTOR(ES)

Charles, Catherine H.

FONTE

American Society for Microbiology

RESUMO

We have developed a technology for improving avidity by making bivalent, trivalent, or tetravalent recombinant polypeptides. We designed tripartite proteins consisting of the Fab fragment of an antibody fused with a hinge derived from human immunoglobulin D that was further linked to polymerization domains derived from human coiled-coil proteins. We report here on the application of this method with a Fab domain directed against the major human rhinovirus receptor, intercellular adhesion molecule 1 (ICAM-1). Multivalent anti-ICAM-1 molecules were produced in bacteria and purified as soluble preassembled homogeneous proteins at high yield. These proteins successfully blocked rhinovirus infection in vitro, with the efficiency increasing from monomer to dimer, trimer, and tetramer. The diminished dissociation rate of these multivalent antibodies and their improved efficacy in preventing rhinovirus infection provide a foundation for producing prophylactic and therapeutic molecules against human rhinovirus, the causative agent of the majority of common colds.

Documentos Relacionados

• Discrimination among Rhinovirus Serotypes for a Variant ICAM-1 Receptor Molecule
• Human-murine chimeras of ICAM-1 identify amino acid residues critical for rhinovirus and antibody binding.
• Structural Analysis of Human Rhinovirus Complexed with ICAM-1 Reveals the Dynamics of Receptor-Mediated Virus Uncoating
• The Domain Structure of ICAM-1 and the Kinetics of Binding to Rhinovirus
• Efficient neutralization and disruption of rhinovirus by chimeric ICAM-1/immunoglobulin molecules.